Advisory Council for the Elimination of Tuberculosis (ACET), 23372-23373 [2021-09006]

Download as PDF 23372 Federal Register / Vol. 86, No. 83 / Monday, May 3, 2021 / Notices Dated: April 27, 2021. Marquita Cullom, Associate Director. [FR Doc. 2021–09180 Filed 4–30–21; 8:45 am] BILLING CODE 4160–90–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC, announces the following meeting of the Advisory Board on Radiation and Worker Health (ABRWH or Advisory Board). This meeting is open to the public, but without a public comment period. The public is welcome to submit written comments in advance of the meeting, to the contact person below. Written comments received in advance of the meeting will be included in the official record of the meeting. The public is also welcome to listen to the meeting by joining the teleconference (information below). The audio conference line has 150 ports for callers. DATES: The meeting will be held on June 23, 2021, from 10:30 a.m. to 1:00 p.m., EDT. Written comments must be received on or before June 16, 2021. ADDRESSES: You may submit comments by mail to: Sherri Diana, National Institute for Occupational Safety and Health, 1090 Tusculum Avenue, MS C–34, Cincinnati, Ohio 45226. Meeting Information: Audio Conference Call via FTS Conferencing. The USA toll-free dial-in number is 1–866–659–0537; and the passcode is 9933701. SUMMARY: jbell on DSKJLSW7X2PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated Federal Officer, NIOSH, CDC, 1090 Tusculum Avenue, Mailstop C–24, Cincinnati, Ohio 45226, Telephone: (513) 533–6800, Toll Free 1 (800) CDC– INFO, Email: ocas@cdc.gov. SUPPLEMENTARY INFORMATION: Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to VerDate Sep<11>2014 20:34 Apr 30, 2021 Jkt 253001 implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines which have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule, advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The Advisory Board’s charter was issued on August 3, 2001, renewed at appropriate intervals, rechartered on March 22, 2020, and will terminate on March 22, 2022. Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters To Be Considered: The agenda will include discussions on: Work Group and Subcommittee Reports; Update on the Status of SEC Petitions; and plans for the August 2021 Advisory Board meeting. Agenda items are subject to change as priorities dictate. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and PO 00000 Frm 00031 Fmt 4703 Sfmt 4703 Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–09007 Filed 4–30–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Council for the Elimination of Tuberculosis (ACET) Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Advisory Council for the Elimination of Tuberculosis Meeting (ACET). This meeting is open to the public and limited to 1,000 audio and web conference lines. Time will be available for public comment. DATES: The meeting will be held on June 15, 2021, from 10:00 a.m. to 3:45 p.m., EDT, and June 16, 2021, from 10:00 a.m. to 12:00 p.m., EDT. The public is welcome to submit written comments in advance of the meeting. Comments should be submitted in writing by email to the contact person listed below. In the subject line, please note ATTN: Staci for ACET Public Comment. The public comment should include your name, affiliation, and email address. Comments must be received on or before June 14, 2021. ADDRESSES: The web conference access is: https://cdc.zoomgov.com/j/ 1612817912?pwd=dFRoNDJvWjh 3Q0NtTDFjWnJya2xJZz09 Passcode: 8ed4G7=S Webinar ID: 161 281 7912 The teleconference access is noted as follows: Telephone number: 1–669–254–5252; and the passcode is 53466615. FOR FURTHER INFORMATION CONTACT: Staci Morris, Committee Management Specialist, CDC, 1600 Clifton Road NE, Mailstop US8–6, Atlanta, Georgia 30329–4027; Telephone: (404) 718– 7479; Email: nchhstppolicy@cdc.gov. (In the subject line, please note ATTN: Staci for ACET Public Comment.) SUPPLEMENTARY INFORMATION: Purpose: This Council advises and makes recommendations to the SUMMARY: E:\FR\FM\03MYN1.SGM 03MYN1 Federal Register / Vol. 86, No. 83 / Monday, May 3, 2021 / Notices Secretary of Health and Human Services, the Assistant Secretary for Health, and the Director, CDC, regarding the elimination of tuberculosis. Specifically, the Council makes recommendations regarding policies, strategies, objectives, and priorities; addresses the development and application of new technologies; and reviews the extent to which progress has been made toward eliminating tuberculosis. Matters to be Considered: The agenda will include discussions on (1) 2020 TB provisional surveillance data; (2) Tuberculosis Trials Consortium Update; (3) COVID impact on TB programs; (4) Perceptions of non-U.S.-born persons on the link between country of birth and TB risk; (5) Using Big Data to Understand Latent Tuberculosis Care in the United States; and (6) Bacillus Calmette-Guerin Vaccine Guidance Development. Agenda items are subject to change as priorities dictate. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2021–09006 Filed 4–30–21; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–9130–N] ACTION: Notice. This quarterly notice lists CMS manual instructions, substantive and interpretive regulations, and other Federal Register notices that were published from January through March 2021, relating to the Medicare and Medicaid programs and other programs administered by CMS. SUMMARY: It is possible that an interested party may need specific information and not be able to determine from the listed information whether the issuance or regulation would fulfill that need. Consequently, we are providing contact persons to answer general questions concerning each of the addenda published in this notice: FOR FURTHER INFORMATION CONTACT: Medicare and Medicaid Programs; Quarterly Listing of Program Issuances—January Through March 2021 Centers for Medicare & Medicaid Services (CMS), HHS. AGENCY: Addenda Contact I CMS Manual Instructions ......................................................................................................... II Regulation Documents Published in the Federal Register ................................................... III CMS Rulings .......................................................................................................................... IV Medicare National Coverage Determinations ........................................................................ V FDA-Approved Category B IDEs ............................................................................................ VI Collections of Information ...................................................................................................... VII Medicare-Approved Carotid Stent Facilities ......................................................................... VIII American College of Cardiology-National Cardiovascular Data Registry Sites .................. IX Medicare’s Active Coverage-Related Guidance Documents ................................................ X One-time Notices Regarding National Coverage Provisions ................................................. XI National Oncologic Positron Emission Tomography Registry Sites ..................................... XII Medicare-Approved Ventricular Assist Device (Destination Therapy) Facilities .................. XIII Medicare-Approved Lung Volume Reduction Surgery Facilities ......................................... XIV Medicare-Approved Bariatric Surgery Facilities .................................................................. XV Fluorodeoxyglucose Positron Emission Tomography for Dementia Trials .......................... All Other Information ..................................................................................................................... Ismael Torres ..................... Terri Plumb ......................... Tiffany Lafferty ................... Wanda Belle, MPA ............. John Manlove ..................... William Parham .................. Sarah Fulton, MHS ............ Sarah Fulton, MHS ............ JoAnna Baldwin, MS .......... JoAnna Baldwin, MS .......... David Dolan, MBA .............. David Dolan, MBA .............. Sarah Fulton, MHS ............ Sarah Fulton, MHS ............ David Dolan, MBA .............. Annette Brewer .................. SUPPLEMENTARY INFORMATION: I. Background jbell on DSKJLSW7X2PROD with NOTICES delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. The Centers for Medicare & Medicaid Services (CMS) is responsible for administering the Medicare and Medicaid programs and coordination and oversight of private health insurance. Administration and oversight of these programs involves the following: (1) Furnishing information to Medicare and Medicaid beneficiaries, health care providers, and the public; and (2) maintaining effective communications with CMS regional offices, state governments, state Medicaid agencies, state survey agencies, various providers of health care, all Medicare contractors that process claims and pay bills, National VerDate Sep<11>2014 20:34 Apr 30, 2021 Jkt 253001 23373 Association of Insurance Commissioners (NAIC), health insurers, and other stakeholders. To implement the various statutes on which the programs are based, we issue regulations under the authority granted to the Secretary of the Department of Health and Human Services under sections 1102, 1871, 1902, and related provisions of the Social Security Act (the Act) and Public Health Service Act. We also issue various manuals, memoranda, and statements necessary to administer and oversee the programs efficiently. Section 1871(c) of the Act requires that we publish a list of all Medicare manual instructions, interpretive rules, statements of policy, and guidelines of general applicability not issued as PO 00000 Frm 00032 Fmt 4703 Sfmt 4703 Phone No. (410) 786–1864 (410) 786–4481 (410)786–7548 (410) 786–7491 (410) 786–6877 (410) 786–4669 (410) 786–2749 (410) 786–2749 (410) 786–7205 (410) 786–7205 (410) 786–3365 (410) 786–3365 (410) 786–2749 (410) 786–2749 (410) 786–3365 (410) 786–6580 regulations at least every 3 months in the Federal Register. II. Format for the Quarterly Issuance Notices This quarterly notice provides only the specific updates that have occurred in the 3-month period along with a hyperlink to the full listing that is available on the CMS website or the appropriate data registries that are used as our resources. This is the most current up-to-date information and will be available earlier than we publish our quarterly notice. We believe the website list provides more timely access for beneficiaries, providers, and suppliers. We also believe the website offers a more convenient tool for the public to find the full list of qualified providers E:\FR\FM\03MYN1.SGM 03MYN1

Agencies

[Federal Register Volume 86, Number 83 (Monday, May 3, 2021)]
[Notices]
[Pages 23372-23373]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-09006]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Council for the Elimination of Tuberculosis (ACET)

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC 
announces the following meeting of the Advisory Council for the 
Elimination of Tuberculosis Meeting (ACET). This meeting is open to the 
public and limited to 1,000 audio and web conference lines. Time will 
be available for public comment.

DATES: The meeting will be held on June 15, 2021, from 10:00 a.m. to 
3:45 p.m., EDT, and June 16, 2021, from 10:00 a.m. to 12:00 p.m., EDT.
    The public is welcome to submit written comments in advance of the 
meeting. Comments should be submitted in writing by email to the 
contact person listed below. In the subject line, please note ATTN: 
Staci for ACET Public Comment. The public comment should include your 
name, affiliation, and email address.
    Comments must be received on or before June 14, 2021.

ADDRESSES: The web conference access is: https://cdc.zoomgov.com/j/1612817912?pwd=dFRoNDJvWjh3Q0NtTDFjWnJya2xJZz09

Passcode: 8ed4G7=S
Webinar ID: 161 281 7912

    The teleconference access is noted as follows:
    Telephone number: 1-669-254-5252; and the passcode is 53466615.

FOR FURTHER INFORMATION CONTACT: Staci Morris, Committee Management 
Specialist, CDC, 1600 Clifton Road NE, Mailstop US8-6, Atlanta, Georgia 
30329-4027; Telephone: (404) 718-7479; Email: [email protected]. 
(In the subject line, please note ATTN: Staci for ACET Public Comment.)

SUPPLEMENTARY INFORMATION:
    Purpose: This Council advises and makes recommendations to the

[[Page 23373]]

Secretary of Health and Human Services, the Assistant Secretary for 
Health, and the Director, CDC, regarding the elimination of 
tuberculosis. Specifically, the Council makes recommendations regarding 
policies, strategies, objectives, and priorities; addresses the 
development and application of new technologies; and reviews the extent 
to which progress has been made toward eliminating tuberculosis.
    Matters to be Considered: The agenda will include discussions on 
(1) 2020 TB provisional surveillance data; (2) Tuberculosis Trials 
Consortium Update; (3) COVID impact on TB programs; (4) Perceptions of 
non-U.S.-born persons on the link between country of birth and TB risk; 
(5) Using Big Data to Understand Latent Tuberculosis Care in the United 
States; and (6) Bacillus Calmette-Guerin Vaccine Guidance Development. 
Agenda items are subject to change as priorities dictate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2021-09006 Filed 4-30-21; 8:45 am]
BILLING CODE 4163-18-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.